Magnesphere for Autonomic Alteration (NCT04207476) | Clinical Trial Compass
WithdrawnNot Applicable
Magnesphere for Autonomic Alteration
Stopped: Study was never initiated due to COVID and computer difficulties.
United States0Started 2021-07-25
Plain-language summary
To evaluate the physiologic effects of an electromagnetic resonator(EMF) on autonomic nervous system tone modulation through measurement of heart rate variability(HRV).
Null Hypothesis: An EMF Resonator will not change autonomic nervous system tone and no demonstrable difference in physiological parameters will recorded.
Alternative Hypothesis: Using an EMF Resonator will enhance parasympathetic activty as supported by HRV.
Who can participate
Age range
18 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Male and female patients more than 18 years old with LVEF of \< 40%(N=20)
. Healthy age matched controls (N=20)
. Ability to lay in a reclining chair for at least 60 minutes
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1I found a trial called Magnesphere for Autonomic Alteration that was studying heart rate variability in heart failure with reduced ejection fraction, but it shows as 'withdrawn' — do you know why it was pulled, and does that tell us anything important about this approach?
2Since this trial was withdrawn before completing, is there other evidence about whether Magnesphere or similar magnetic resonance therapy might help with the nervous system imbalances that come with reduced ejection fraction heart failure?
3Heart rate variability was what this trial planned to measure — can you explain why HRV matters in my specific type of heart failure, and whether improving it is something we should be actively targeting in my care?
4Are there any currently active or completed trials looking at non-drug approaches to autonomic dysfunction in heart failure with reduced ejection fraction that might be worth exploring instead of this withdrawn one?
5Given that this trial never finished and has no phase listed, meaning very little safety or benefit data exists for this device in my condition, what standard treatments should I make sure we've fully considered first?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.